Your browser doesn't support javascript.
loading
Deferasirox AUC efficacy cutoff and role of pharmacogenetics.
Allegra, S; Cusato, J; De Francia, S; Massano, D; Piga, A; D'Avolio, A.
Afiliação
  • Allegra S; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, Unit of Infectious Diseases, Amedeo di Savoia Hospital University of TorinoCorso Svizzera 16410149 TurinItaly, University of Turin, 10149, Turin, Italy.
  • Cusato J; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, Unit of Infectious Diseases, Amedeo di Savoia Hospital University of TorinoCorso Svizzera 16410149 TurinItaly, University of Turin, 10149, Turin, Italy.
  • De Francia S; Department of Biological and Clinical Sciences, S. Luigi Gonzaga Hospital, University of Turin, 10043, Orbassano, TO, Italy.
  • Massano D; Department of Pediatrics, Centre for Microcitemie, S. Luigi Gonzaga Hospital, University of Turin, 10043, Orbassano, TO, Italy.
  • Piga A; Department of Pediatrics, Centre for Microcitemie, S. Luigi Gonzaga Hospital, University of Turin, 10043, Orbassano, TO, Italy.
  • D'Avolio A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, Unit of Infectious Diseases, Amedeo di Savoia Hospital University of TorinoCorso Svizzera 16410149 TurinItaly, University of Turin, 10149, Turin, Italy. antonio.davolio@unito.it.
Eur J Clin Pharmacol ; 72(9): 1155-7, 2016 Sep.
Article em En | MEDLINE | ID: mdl-27193993

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Benzoatos / Quelantes de Ferro / Talassemia beta Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Benzoatos / Quelantes de Ferro / Talassemia beta Idioma: En Ano de publicação: 2016 Tipo de documento: Article